Targeting TLR4 and regulating the Keap1/Nrf2 pathway with andrographolide to suppress inflammation and ferroptosis in LPS-induced acute lung injury

Abstract

Acute lung injury (ALI) is a severe inflammatory condition with a high mortality rate, often precipitated by sepsis. The pathophysiology of ALI involves complex mechanisms, including inflammation, oxidative stress, and ferroptosis, a novel form of regulated cell death. This study explores the therapeutic potential of andrographolide (AG), a bioactive compound derived from Andrographis, in mitigating Lipopolysaccharide (LPS)-induced inflammation and ferroptosis. Our research employed in vitro experiments with RAW264.7 macrophage cells and in vivo studies using a murine model of LPS-induced ALI. The results indicate that AG significantly suppresses the production of pro-inflammatory cytokines and inhibits ferroptosis in LPS-stimulated RAW264.7 cells. In vivo, AG treatment markedly reduces lung edema, decreases inflammatory cell infiltration, and mitigates ferroptosis in lung tissues of LPS-induced ALI mice. These protective effects are mediated via the modulation of the Toll-like receptor 4 (TLR4)/Kelch-like ECH-associated protein 1(Keap1)/Nuclear factor erythroid 2-related factor 2 (Nrf2) signaling pathway. Molecular docking simulations identified the binding sites of AG on the TLR4 protein (Kd value: −33.5 kcal·mol⁻¹), and these interactions were further corroborated by Cellular Thermal Shift Assay (CETSA) and SPR assays. Collectively, our findings demonstrate that AG exerts potent anti-inflammatory and anti-ferroptosis effects in LPS-induced ALI by targeting TLR4 and modulating the Keap1/Nrf2 pathway. This study underscores AG’s potential as a therapeutic agent for ALI and provides new insights into its underlying mechanisms of action.

Keywords

Andrographolide / Acute lung injury / Ferroptosis / Toll-like receptor 4 / Kelch-like ECH-associated protein 1/Nuclear factor erythroid 2-related factor 2

References

[1] Rudd KE, Johnsonet SC, Agesaal KM, et al. Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study[J]. Lancet, 2020, 395: 200-211.

[2] Sevransky JE, Martin GS, Shanholtz C, et al. Mortality in sepsis versus non-sepsis induced acute lung injury[J]. Crit Care, 2009, 13: 1-6.

[3] Yuan R, He J, Huang LT, et al. Anemoside B4 protects against acute lung injury by attenuating inflammation through blocking NLRP3 Inflammasome activation and TLR4 dimerization[J]. J Immunol Res, 2020, 2020: 7502301.

[4] He RY, Liu BH, Xiong R, et al. Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury[J]. Cell Death Discov, 2022, 8: 43.

[5] Han S, Yuan R, Cui YS, et al. Hederasaponin C alleviates lipopolysaccharide-induced acute lung injury in vivo and in vitro through the PIP2/NF-κB/NLRP3 signaling pathway[J]. Front Immunol, 2022, 13: 846384.

[6] Yuan Y, Zhai Y, Chen J, et al. Kaempferol ameliorates oxygen-glucose deprivation/reoxygenation-induced neuronal ferroptosis by activating Nrf2/SLC7A11/GPX4 axis[J]. Biomolecules, 2021, 11: 923.

[7] Yang SJ, Xie ZP, Zeng Y, et al. Salidroside attenuates neuronal ferroptosis by activating the Nrf2/HO1 signaling pathway in Aβ1-42-induced Alzheimer’s disease mice and glutamate-injured HT22 cells[J]. Chin Med (UK), 2022, 17: 1-18.

[8] Bebber CM, Müller F, Clemente LP, et al. Ferroptosis in cancer cell biology[J]. Cancers, 2020, 12: 164.

[9] Wu JR, Tuo QZ, Lei P. Ferroptosis, a recent defined form of critical cell death in neurological disorders[J]. J Mol Neurosci, 2018, 66: 197-206.

[10] Li XY, Ma N, Xu JP, et al. Targeting ferroptosis: pathological mechanism and treatment of ischemia-reperfusion injury[J]. Oxid Med Cell Longev, 2021, 2021: 1587922.

[11] Liu X, Zhang J, Xie W. The role of ferroptosis in acute lung injury[J]. Mol Cell Biochem, 2022, 477: 1453-1461.

[12] Li N, Wang W, Zhou H, et al. Ferritinophagy-mediated ferroptosis is involved in sepsis-induced cardiac injury[J]. Free Radical Bio Med, 2020, 160: 303-318.

[13] Mishima E, Sato E, Ito J, et al. Drugs repurposed as antiferroptosis agents suppress organ damage, including AKI, by functioning as lipid peroxyl radical scavengers[J]. J Am Soc Nephrol, 2020, 31: 280-296.

[14] Liu PF, Feng YT, Li HW, et al. Ferrostatin-1 alleviates lipopolysaccharide-induced acute lung injury via inhibiting ferroptosis[J]. Cell Mol Biol Lett, 2020, 25: 1-14.

[15] Shi K, Xiao YX, Dong Y, et al. Protective effects of Atractylodis lancea Rhizoma on lipopolysaccharide-induced acute lung injury via TLR4/NF-κB and Keap1/Nrf2 signaling pathways in vitro and in vivo[J]. Int J Mol Sci, 2022, 23: 16134.

[16] He J, Yuan R, Cui XL, et al. Anemoside B4 protects againstKlebsiella pneumoniae- and influenza virus FM1-induced pneumonia via the TLR4/Myd88 signaling pathway in mice[J]. Chin Med (UK), 2020, 15: 1-13.

[17] Lee SS, Katkar GD, Tam JL, et al. TLR4 signaling and macrophage inflammatory responses are dampened by GIV/ Girdin[J]. PNAS, 2020, 117: 26895-26906.

[18] Han S, Gao HW, Chen SR, et al. Procyanidin A1 alleviates inflammatory response induced by LPS through NF-κB, MAPK, and Nrf2/HO-1 pathways in RAW264.7 cells[J]. Sci Rep (UK), 2019, 9: 15087.

[19] Zhou D, Chang W, Qi J, et al. Lung protective effects of dietary malate esters derivatives from Bletilla striata against SiO2 nanoparticles through activation of Nrf2 pathway[J]. Chin Herb Med, 2023, 15(1): 76-85.

[20] Li JC, Lu KM, Sun FL, et al. Panaxydol attenuates ferroptosis against LPS-induced acute lung injury in mice by Keap1-Nrf2/HO-1 pathway[J]. J Transl Med, 2021, 19: 96.

[21] Talei D, Valdiani A, Maziah M, et al. Salt stress-induced protein pattern associated with photosynthetic parameters and andrographolide content in Andrographis paniculata Nees[J]. Biosci Biotech Bioch, 2015, 79: 51-58.

[22] Li Y, He SN, Tang JS, et al. Andrographolide inhibits inflammatory cytokines secretion in LPS-stimulated RAW264. 7 cells through suppression of NF-κB/MAPK signaling pathway[J]. Evid-Based Compl Alt, 2017, 2017: 8248142.

[23] Varma A, Padh H, Shrivastava N. Andrographolide: a new plant-derived antineoplastic entity on horizon[J]. Evid-Based Compl Alt, 2011, 2011: 815390.

[24] Latif R, Wang CY. Andrographolide as a potent and promising antiviral agent[J]. Chin J Nat Med, 2020, 18(10): 760-769.

[25] Banerjee M, Parai D, Chattopadhyay S, et al. Andrographolide: antibacterial activity against common bacteria of human health concern and possible mechanism of action[J]. Folia Microbiol, 2017, 62: 237-244.

[26] Mussard E, Cesaro A, Lespessailles E, et al. Andrographolide, a natural antioxidant: an update[J]. Antioxidants (Basel, Switzerland), 2019, 8(12): 571.

[27] Zhang SB, Hong M, Sun XY. Silybin has therapeutic efficacy against non-small cell lung cancer through targeting of Skp2[J]. Acta Mater Med, 2022, 1(3):302-313.

[28] Zhao T, Guo X, Sun Y. Iron accumulation and lipid peroxidation in the aging retina: implication of ferroptosis in age-related macular degeneration[J]. Aging Dis, 2021, 12: 529.

[29] Dodson M, Castro-Portuguez R, Zhang DD. NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis[J]. Redox Biol, 2019, 23: 101107.

[30] Zhu JH, Xiong YX, Zhang YX, et al. The molecular mechanisms of regulating oxidative stress-induced ferroptosis and therapeutic strategy in tumors[J]. Oxid Med Cell Longev, 2020, 2020: 1-14.

[31] Ryan SK, Zelic M, Han YN, et al. Microglia ferroptosis is regulated by SEC24B and contributes to neurodegeneration[J]. Nat Neurosci, 2023, 26: 12-26.

[32] Mou YH, Wang J, Wu JC, et al. Ferroptosis, a new form of cell death: opportunities and challenges in cancer[J]. J Hematol Oncol, 2019, 12: 34.

[33] Chen J, Li X, Ge C, et al. The multifaceted role of ferroptosis in liver disease[J]. Cell Death Differ, 2022, 29: 467-480.

[34] Li N, Jiang WY, Wang W, et al. Ferroptosis and its emerging roles in cardiovascular diseases[J]. Pharmacol Res, 2021, 166: 105466.

[35] Li XH, Yuan WC, Wu JB, et al. Andrographolide, a natural anti-inflammatory agent: an update[J]. Front Pharmacol, 2022, 13: 920435.

[36] Abu-Ghefreh AA, Canatan H, Ezeamuzie CI. In vitro and in vivo anti-inflammatory effects of andrographolide[J]. Int Immunopharmacol, 2009, 9: 313-318.

[37] Peng S, Hang N, Liu W, et al. Andrographolide sulfonate ameliorates lipopolysaccharide-induced acute lung injury in mice by down-regulating MAPK and NF-κB pathways[J]. Acta Pharm Sin B, 2016, 6: 205-211.

[38] Gauthier AE, Rotjan RD, Kagan JC. Lipopolysaccharide detection by the innate immune system may be an uncommon defence strategy used in nature[J]. Open Biol, 2022, 12: 220146.

[39] Feng RK, Xiong YF, Lei YR, et al. Lysine-specific demethylase 1 aggravated oxidative stress and ferroptosis induced by renal ischemia and reperfusion injury through activation of TLR4/NOX4 pathway in mice[J]. J Cell Mol Med, 2022, 26: 4254-4267.

[40] Zhu KY, Zhu X, Sun SH, et al. Inhibition of TLR4 prevents hippocampal hypoxic-ischemic injury by regulating ferroptosis in neonatal rats[J]. Exp Neurol, 2021, 345: 113828.

[41] Zhang LF, Zhang XY, Wang AC, et al. Bidirectional crosstalk of the cAMP/ROS-dependent signaling pathways in inflammatory macrophage: an activation of formononetin[J]. Toxicol Appl Pharm, 2023, 472: 116571.

[42] Park C, Cha HJ, Lee H, et al. The regulation of the TLR4/NF-κB and Nrf2/HO-1 signaling pathways is involved in the inhibition of lipopolysaccharide-induced inflammation and oxidative reactions by morroniside in RAW 264.7 macrophages[J]. Arch Biochem Biophys, 2021, 706: 108926.

[43] Xiang Q, Zhao YZ, Lin JL, et al. The Nrf2 antioxidant defense system in intervertebral disc degeneration: molecular insights[J]. Exp Mol Med, 2022, 54: 1067-1075.

[44] Song XH, Long DX. Nrf2 and ferroptosis: a new research direction for neurodegenerative diseases[J]. Front Neurosci (Switz), 2020, 14: 267.

[45] Kerins MJ, Ooi A. The roles of NRF2 in modulating cellular iron homeostasis[J]. Antioxid Redox Sign, 2018, 29: 1756-1773.

[46] Zhang DG, Shen FQ, Ma ST, et al. Andrographolide alleviates paraquat-induced acute lung injury by activating the Nrf2/HO-1 pathway[J]. Iran J Basic Med Sci, 2023, 26: 653-661.

[47] Kose T, Sharp PA, Latunde-Dada GO. Upregulation of Nrf2 signalling and the inhibition of erastin-induced ferroptosis by ferulic acid in MIN6 cells[J]. Int J Mol Sci, 2022, 23: 15886.

[48] Liu N, Lin XL, Huang CY. Activation of the reverse transsulfuration pathway through NRF2/CBS confers erastin-induced ferroptosis resistance[J]. Brit J Cancer, 2020, 122: 279-292.

Funding

China-ASEAN International Innovative Center for Health Industry of Traditional Chinese Medicine(AD20297142)

Guangxi Collaborative Innovation Center for Scientific Achievements Transformation and Applicationon Traditional Chinese Medicine(05020058)